1. Home
  2. NWL vs TRVI Comparison

NWL vs TRVI Comparison

Compare NWL & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newell Brands Inc.

NWL

Newell Brands Inc.

HOLD

Current Price

$4.91

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$14.46

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWL
TRVI
Founded
1903
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
NWL
TRVI
Price
$4.91
$14.46
Analyst Decision
Buy
Strong Buy
Analyst Count
9
11
Target Price
$4.97
$21.55
AVG Volume (30 Days)
9.0M
916.5K
Earning Date
05-01-2026
05-05-2026
Dividend Yield
7.11%
N/A
EPS Growth
N/A
31.91
EPS
N/A
N/A
Revenue
$14,742,200,000.00
N/A
Revenue This Year
$1.19
N/A
Revenue Next Year
$1.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.14
N/A
52 Week Low
$3.07
$5.41
52 Week High
$6.64
$16.12

Technical Indicators

Market Signals
Indicator
NWL
TRVI
Relative Strength Index (RSI) 71.75 56.04
Support Level $4.83 $10.07
Resistance Level $5.14 $14.57
Average True Range (ATR) 0.28 0.58
MACD 0.16 -0.03
Stochastic Oscillator 94.72 80.34

Price Performance

Historical Comparison
NWL
TRVI

About NWL Newell Brands Inc.

Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: